|
DE60135780D1
(en)
*
|
2000-12-25 |
2008-10-23 |
Daiichi Sankyo Co Ltd |
ASPIRIN-CONTAINING MEDICAL COMPOSITIONS
|
|
CA2493384A1
(en)
*
|
2002-07-18 |
2004-01-29 |
Sankyo Company Limited |
Medicinal composition for treating arteriosclerosis
|
|
EP1660183A2
(en)
*
|
2003-05-05 |
2006-05-31 |
Eli Lilly and Company |
Treating cardiovascular diseases with a compound of formula 1 (cs 747 - prasugrel; rn 150322-43-4)
|
|
US20060099262A1
(en)
*
|
2004-11-08 |
2006-05-11 |
Biokey, Inc. |
Methods and formulations for making controlled release oral dosage form
|
|
US8586085B2
(en)
*
|
2004-11-08 |
2013-11-19 |
Biokey, Inc. |
Methods and formulations for making pharmaceutical compositions containing bupropion
|
|
US20060099261A1
(en)
*
|
2004-11-08 |
2006-05-11 |
Biokey, Inc. |
Methods and formulations for making controlled release oral dosage form
|
|
CN1318428C
(en)
*
|
2005-02-23 |
2007-05-30 |
天津药物研究院 |
Thiophenopyridine substituted acetyl hyarazine derivative
|
|
TWI318571B
(en)
*
|
2005-06-10 |
2009-12-21 |
Lilly Co Eli |
Formulation of a thienopyridine platelet aggregation inhibitor
|
|
KR20080016647A
(en)
*
|
2005-06-17 |
2008-02-21 |
일라이 릴리 앤드 캄파니 |
Dosage regimen for prasugrel
|
|
EP1940399A2
(en)
*
|
2005-08-19 |
2008-07-09 |
Eli Lilly & Company |
Use of par-i/par- 4 inhibitors for treating or preventing vascular diseases
|
|
US8056072B2
(en)
|
2005-10-31 |
2011-11-08 |
Microsoft Corporation |
Rebootless display driver upgrades
|
|
CN101460154B
(en)
|
2006-04-04 |
2015-07-01 |
Kg艾克维泽生公司 |
Oral dosage forms including an antiplatelet agent and an acid inhibitor
|
|
TWI392681B
(en)
|
2006-04-06 |
2013-04-11 |
Daiichi Sankyo Co Ltd |
Prasugrel with high purity and a method for preparing its acid addition salt
|
|
PL2032521T3
(en)
*
|
2006-06-27 |
2010-05-31 |
Sandoz Ag |
New method for salt preparation
|
|
WO2008060934A2
(en)
*
|
2006-11-14 |
2008-05-22 |
Acusphere, Inc. |
Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
|
|
EP2100606A4
(en)
*
|
2006-12-07 |
2009-12-30 |
Daiichi Sankyo Co Ltd |
Film-coated preparation having improved stability
|
|
CA2672157C
(en)
*
|
2006-12-07 |
2016-07-26 |
Daiichi Sankyo Company, Limited |
Method for producing solid preparation
|
|
TWI482641B
(en)
*
|
2006-12-07 |
2015-05-01 |
Daiichi Sankyo Co Ltd |
Pharmaceutical composition containing low substituted hydroxypropylcellulose
|
|
US20100280064A1
(en)
*
|
2006-12-07 |
2010-11-04 |
Tomoyuki Watanabe |
Pharmaceutical composition having improved storage stability
|
|
TWI428151B
(en)
*
|
2006-12-07 |
2014-03-01 |
Daiichi Sankyo Co Ltd |
Solid formulations containing mannitol or lactose
|
|
DK2123656T3
(en)
*
|
2007-03-02 |
2014-09-08 |
Daiichi Sankyo Co Ltd |
PROCEDURE FOR PREPARING HIGH PURITY PRASUGREL HYDROCHLORIDE
|
|
KR20150041173A
(en)
|
2007-04-27 |
2015-04-15 |
사이덱스 파마슈티칼스, 인크. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
|
CZ302135B6
(en)
*
|
2007-07-09 |
2010-11-10 |
Zentiva, A. S. |
Process for preparing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4, 5, 6, 7-tetrahydrothieno[3,2-c]-pyridin-2-yl acetate (prasugrel)
|
|
EP2205611A4
(en)
*
|
2007-11-09 |
2012-02-22 |
Reddys Lab Ltd Dr |
Processes for the preparation of prasugrel, and its salts and polymorphs
|
|
HU230261B1
(en)
*
|
2007-11-27 |
2015-11-30 |
Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság |
Process for producing pharmaceutical intermediers
|
|
CN101177430A
(en)
*
|
2007-12-11 |
2008-05-14 |
鲁南制药集团股份有限公司 |
Hydrogenated pyridine derivative and method for preparing salt thereof
|
|
DE112009000268T5
(en)
|
2008-02-06 |
2011-06-01 |
Helm Ag |
Prasugrel salts with improved properties
|
|
WO2009129983A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Ratiopharm Gmbh |
Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
|
|
DE602008002820D1
(en)
|
2008-04-25 |
2010-11-11 |
Sandoz Ag |
Hydrogen sulfate of 2-acetoxy-5- (α-cyclopropylcarbonyl-2-fluorobenzyl) -4,5,6,7-tetrahydrothienoÄ3,2-cpyridine and its preparation
|
|
US20090281136A1
(en)
*
|
2008-05-08 |
2009-11-12 |
Sandeep Mhetre |
Prasugrel pharmaceutical formulations
|
|
US8759316B2
(en)
*
|
2008-05-13 |
2014-06-24 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
|
US9427448B2
(en)
|
2009-11-11 |
2016-08-30 |
The Medicines Company |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
|
US20130303477A1
(en)
*
|
2008-05-13 |
2013-11-14 |
The Medicines Company |
Maintenance of Platelet Inhibition During Antiplatelet Therapy
|
|
US20120141468A1
(en)
*
|
2008-05-13 |
2012-06-07 |
Lisa Ruderman Chen |
Maintenance of platelet inhibition during antiplatelet therapy
|
|
WO2009140092A1
(en)
|
2008-05-13 |
2009-11-19 |
The Medicines Company |
Maintenance of platelet inhibition during antiplatelet therapy
|
|
KR20110045034A
(en)
*
|
2008-08-02 |
2011-05-03 |
루난 파마슈티컬 그룹 코퍼레이션 |
Prasugrel hydrogen sulfate and pharmaceutical compositions and uses thereof
|
|
SI2398468T1
(en)
|
2009-02-17 |
2017-03-31 |
Krka, D.D., Novo Mesto |
Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
|
|
WO2010111951A1
(en)
|
2009-03-31 |
2010-10-07 |
上海医药工业研究院 |
Crystals of prasugrel hydrobromate
|
|
US20120121706A1
(en)
|
2009-04-10 |
2012-05-17 |
Tufts Medical Center, Inc. |
PAR-1 Activation by Metalloproteinase-1 (MMP-1)
|
|
KR101991367B1
(en)
|
2009-05-13 |
2019-06-21 |
사이덱스 파마슈티칼스, 인크. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
|
EP2451816A4
(en)
*
|
2009-07-06 |
2013-02-27 |
Glenmark Generics Ltd |
Crystalline form of prasugrel hydrobromide, preparation and application thereof
|
|
DE102009036646A1
(en)
|
2009-08-07 |
2011-02-10 |
Ratiopharm Gmbh |
Prasugrel in non-crystalline form and pharmaceutical composition thereof
|
|
CN101993447A
(en)
|
2009-08-26 |
2011-03-30 |
浙江华海药业股份有限公司 |
Method for synthesizing Prasugrel artificially
|
|
WO2011036533A1
(en)
|
2009-09-23 |
2011-03-31 |
Glenmark Pharmaceuticals Limited |
Pharmaceutical composition comprising prasugrel and triflusal
|
|
PL2498731T3
(en)
|
2009-11-11 |
2020-07-13 |
Chiesi Farmaceutici S.P.A. |
Methods of treating or preventing stent thrombosis
|
|
US10376532B2
(en)
|
2009-11-11 |
2019-08-13 |
Chiesi Farmaceutici, S.P.A. |
Methods of treating, reducing the incidence of, and/or preventing ischemic events
|
|
CZ2009763A3
(en)
|
2009-11-16 |
2011-05-25 |
Zentiva, K. S. |
Process for preparing extreme pure 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate known under unprotected name prasugrel and its novel pharmaceutically acceptable salts
|
|
CZ2009762A3
(en)
|
2009-11-16 |
2011-05-25 |
Zentiva, K. S. |
Novel salts of 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate known under unprotected name prasugrel and process of their preparation
|
|
CZ2009828A3
(en)
|
2009-12-09 |
2011-06-22 |
Zentiva, K.S. |
Process for preparing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride (prasugrelu hydrochloride in polymorphous B form
|
|
HU229035B1
(en)
*
|
2009-12-21 |
2013-07-29 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Process for producing prasurgel
|
|
WO2011092720A2
(en)
*
|
2010-02-01 |
2011-08-04 |
Msn Laboratories Limited |
Pharmaceutical composition of prasugrel and its pharmaceutically acceptable salts
|
|
EP2360159A1
(en)
|
2010-02-11 |
2011-08-24 |
Ratiopharm GmbH |
Prasugrel in micronized, crystalline form and pharmaceutical compound of same
|
|
CN102869668A
(en)
|
2010-03-09 |
2013-01-09 |
斯索恩有限公司 |
Process for making prasugrel
|
|
KR101184915B1
(en)
|
2010-03-11 |
2012-09-21 |
한미사이언스 주식회사 |
Process for preparing high-purity prasugrel
|
|
CA2788764A1
(en)
|
2010-03-23 |
2011-09-29 |
Alembic Pharmaceuticals Limited |
A process for the preparation of prasugrel hcl salt
|
|
EP2377520A1
(en)
|
2010-03-24 |
2011-10-19 |
Ratiopharm GmbH |
Pharmaceutical compound of prasugrel
|
|
CN102212068A
(en)
*
|
2010-04-06 |
2011-10-12 |
刘桂坤 |
Thiofuran derivative, preparation method thereof and application thereof in medicaments
|
|
CN102212071B
(en)
*
|
2010-04-08 |
2014-03-26 |
上海医药工业研究院 |
Prasugrel hydrochloride acetic acid solvate as well as crystal and preparation method thereof
|
|
KR101785186B1
(en)
|
2010-04-08 |
2017-10-12 |
테바 파마슈티컬 인더스트리즈 리미티드 |
Crystalline forms of prasugrel salts
|
|
US20130203668A1
(en)
|
2010-04-19 |
2013-08-08 |
Cadila Healthcare Limited |
Pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
|
|
WO2012001486A1
(en)
*
|
2010-06-28 |
2012-01-05 |
Mayuka Labs Pvt. Ltd. |
An improved process for the preparation of prasugrel hydrochloride and its intermediates
|
|
TR201006802A1
(en)
*
|
2010-08-17 |
2012-03-21 |
Sanovel İlaç San. Ve Ti̇c. A.Ş. |
Oral dispersible formulations of prasugrelin.
|
|
EP2409685A3
(en)
|
2010-07-19 |
2012-02-01 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Orally-disintegrating formulations of prasugrel
|
|
TR201007926A1
(en)
|
2010-07-19 |
2012-02-21 |
Sanovel İlaç San.Ve Ti̇c.A.Ş. |
Prasugrel tablet formulations.
|
|
TR201005900A1
(en)
|
2010-07-19 |
2012-02-21 |
Sanovel İlaç San. Ve Ti̇c. A.Ş. |
Prasugrel granules with improved stability.
|
|
WO2012023145A2
(en)
*
|
2010-08-18 |
2012-02-23 |
Hetero Research Foundation |
Prasugrel hydrochloride crystalline particles
|
|
HUP1000565A2
(en)
|
2010-10-22 |
2012-05-02 |
Egis Gyogyszergyar Nyrt |
Process for the preparation of pharmaceutically active compound and intermediers
|
|
CN101985450B
(en)
*
|
2010-11-02 |
2012-07-11 |
北京赛科药业有限责任公司 |
Prasugrel salt and preparation method thereof
|
|
CN102532157A
(en)
*
|
2010-12-16 |
2012-07-04 |
瑞阳制药有限公司 |
Medicinal acid addition salt compounds of prasugrel, and preparation method thereof
|
|
CZ305314B6
(en)
*
|
2010-12-30 |
2015-07-29 |
Zentiva, K.S. |
Novel hydrobromide of the C 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate form known under unprotected name prasugrel and process for preparing thereof
|
|
CN102199163A
(en)
*
|
2011-04-01 |
2011-09-28 |
中国药科大学 |
2-hydroxy tetrahydrothiophene derivative, preparation method thereof and application thereof in pharmacy
|
|
CN102746318A
(en)
*
|
2011-04-20 |
2012-10-24 |
上海信谊药厂有限公司 |
Method for preparation of Prasugrel hydrochloride
|
|
AU2012255137A1
(en)
|
2011-05-17 |
2013-12-12 |
The Brigham And Women's Hospital, Inc. |
Improved platelet storage using a sialidase inhibitor
|
|
US9788539B2
(en)
|
2011-05-17 |
2017-10-17 |
Velico Medical, Inc. |
Platelet protection solution having beta-galactosidase and sialidase inhibitors
|
|
CN102838618A
(en)
*
|
2011-06-22 |
2012-12-26 |
广东东阳光药业有限公司 |
Method for preparing prasugrel, and prasugrel hydrochloride novel crystal forms
|
|
EP2736509B1
(en)
|
2011-07-28 |
2015-09-23 |
Laboratorios Lesvi, S.L. |
Process for preparing prasugrel
|
|
CN103102355A
(en)
*
|
2011-11-09 |
2013-05-15 |
丁克 |
Tetrahydrothienopyridine compound with optical activity
|
|
CZ2011872A3
(en)
|
2011-12-22 |
2013-07-03 |
Zentiva, K.S. |
Pharmaceutical formulation of prasugrel hydrobromide
|
|
US8603537B2
(en)
|
2012-04-02 |
2013-12-10 |
Egis Pharmaceuticals Plc |
Prasugrel containing quickly released stable oral pharmaceutical compositions
|
|
CA2887083A1
(en)
|
2012-10-05 |
2014-04-10 |
Velico Medical, Inc. |
Platelet additive solution having a beta-galactosidase inhibitor
|
|
EP2722036A1
(en)
|
2012-10-19 |
2014-04-23 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Solid oral formulations of prasugrel
|
|
EP2722037A1
(en)
|
2012-10-19 |
2014-04-23 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Prasugrel formulations
|
|
PL402028A1
(en)
|
2012-12-12 |
2014-06-23 |
Instytut Farmaceutyczny |
Method for preparing polymorph B form of Prasugrel hydrochloride in pharmaceutical grade
|
|
HU230649B1
(en)
|
2013-01-24 |
2017-05-29 |
Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság |
Improved process for producing pharmaceutical agent prasugrel and 2-(2-fluorophenyl)-1-cyclopropylethanone intermediate
|
|
WO2014120886A1
(en)
|
2013-01-30 |
2014-08-07 |
Velico Medical, Inc. |
Platelet additive solution having a self-assembling hydrogel-forming peptide
|
|
KR102235732B1
(en)
|
2013-12-26 |
2021-04-02 |
에스케이플래닛 주식회사 |
System and method for managing coupon, apparatus and computer readable medium having computer program recorded therefor
|
|
DE102014108210A1
(en)
|
2014-06-11 |
2015-12-17 |
Dietrich Gulba |
rodenticide
|
|
EP2979693A1
(en)
|
2014-08-01 |
2016-02-03 |
Zaklady Farmaceutyczne Polpharma SA |
Pharmaceutical composition comprising prasugrel or pharmaceutically acceptable salt thereof and process for its preparation
|
|
CN104479502A
(en)
*
|
2014-12-31 |
2015-04-01 |
江阴市天邦涂料股份有限公司 |
Water-base anticorrosive coating
|
|
WO2016122421A1
(en)
|
2015-01-29 |
2016-08-04 |
Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. |
Stable pharmaceutical compositions containing prasugrel base
|
|
EP3106151A1
(en)
|
2015-06-19 |
2016-12-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical compositions of prasugrel hydrobromide
|
|
EP3156049A1
(en)
|
2015-10-15 |
2017-04-19 |
Alembic Pharmaceuticals Limited |
Pharmaceutical composition of prasugrel
|
|
EP3158993A1
(en)
|
2015-10-22 |
2017-04-26 |
Zaklady Farmaceutyczne Polpharma SA |
Process for preparing a tablet comprising prasugrel or pharmaceutically acceptable salt thereof
|
|
HU231079B1
(en)
|
2016-06-23 |
2020-06-29 |
Richter Gedeon Nyrt. |
Process for the preparation of high-purity prasugrel by the elimination of the bromopentyl impurity
|
|
WO2018073437A1
(en)
|
2016-10-21 |
2018-04-26 |
Laboratorios Lesvi, Sl |
Pharmaceutical formulations of prasugrel and processes for the preparation thereof
|
|
CN106632391A
(en)
*
|
2016-12-23 |
2017-05-10 |
山东鲁抗医药股份有限公司 |
Prasugrel hydrochloride compound, preparation method of prasugrel hydrochloride compound and pharmaceutical composition containing prasugrel hydrochloride
|
|
KR20200018481A
(en)
|
2017-06-23 |
2020-02-19 |
키에시 파르마슈티시 엣스. 피. 에이. |
How to prevent pulmonary artery shunt thrombosis
|
|
KR102063862B1
(en)
|
2018-08-09 |
2020-01-08 |
한국기술교육대학교 산학협력단 |
System for managing share point of view based QR code
|
|
KR102491932B1
(en)
|
2020-11-18 |
2023-01-27 |
현대엠시스템즈 주식회사 |
Communication method variable remote monitoring control system and method
|
|
KR102485021B1
(en)
|
2020-11-18 |
2023-01-05 |
효성중공업 주식회사 |
Battery SoC Balancing Control Device for BESS Based on Solid State Transformer with Delta Configuration, and method thereof
|